Anti-TB chemotherapy effect on peripheral blood mononuclear cells from active tuberculosis patients: time course
Summary:
Analysis of PBMCs from patients with active pulmonary tuberculosis (PTB) up to 6 months after initiation of anti-tuberculosis chemotherapy treatment. Results provide insight into the molecular mechanisms associated with PTB.
GPL570:
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array
Citation:
Cai Y, Yang Q, Tang Y, Zhang M et al. Increased complement C1q level marks active disease in human tuberculosis. PLoS One 2014;9(3):e92340. PMID: 24647646
